Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
- 20 October 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (2) , 301-311
Abstract
Breast conservation therapy (BCT) is standard for T1–T2 tumors, but early trials excluded breast cancers > 5 cm. This study was performed to assess patterns and outcomes of BCT for T3 tumors.Keywords
Funding Information
- U.S. Public Health Service (P30 CA006927)
This publication has 20 references indexed in Scilit:
- Preoperative Delays in the US Medicare Population With Breast CancerJournal of Clinical Oncology, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Oncoplastic Breast Surgery for Cancer: Analysis of 540 Consecutive CasesPlastic and Reconstructive Surgery, 2010
- Are Mastectomies on the Rise? A 13-Year Trend Analysis of the Selection of Mastectomy Versus Breast Conservation Therapy in 5865 PatientsAnnals of Surgical Oncology, 2009
- Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical TreatmentJournal of Clinical Oncology, 2007
- Patient Involvement in Surgery Treatment Decisions for Breast CancerJournal of Clinical Oncology, 2005
- Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapyCancer, 2003
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsNew England Journal of Medicine, 1995
- Breast Conservation Management of Breast Tumors 4 cm or LargerArchives of Surgery, 1992
- Psychological Effects of Breast-Conserving Cancer Treatment and MastectomyPsychosomatics, 1990